St. Jude Medical, Inc. STJ, a global medical device company,
today announced U.S. Food and Drug Administration (FDA) approval of the FlexAbilityâ„¢
Ablation Catheter, a new ablation technology used by
electrophysiologists for the treatment of cardiac arrhythmias. Designed
with feedback from leaders in the electrophysiology community, the
FlexAbility catheter combines a bendable irrigated catheter tip with an
advanced handle and next generation shaft design. The unique flexible
tip was developed to conform better to the cardiac anatomy, allowing for
effective lesion formation. This added flexibility, in addition to the
catheter's ability to maneuver easily and reliably in challenging cases,
was designed to enhance the quality of care for patients around the
world who require ablation procedures.
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in